THE HEART

Home | Statins, inflammation & atherogenesis--their failure | understanding heart attack | lipids, lipoproteins, the basics | Understanding Atherosclerosis & its MI Link--jk | Tables of Risk Factors plus STATS | inflammation, obesity and atherosclerosis | Risk Factors Athereosclerosis | High Cholesterol and treatments | STATINS, lowering cholesterol doesn't prolong life | High HDL not Prophylactic | Other Markers for Cardiovascular Disease | Why improving cholesterol profile with statins has little effect | Statins side effects | Statins over prescribed | Recommendation for your heart | New Major Study Pans Statins | STATIN COMBO STUDY, NO BENEFITS | C-Reactive Protein and Statins | Ozone & cholesterol combine to cause heart disease | Serious cognitive impairment from bypass operation, Scientific American | ARRHTYTHMIA, sudden early death and prevention for relatives | STEM CELLS GROW HEART MUSCLE | BYPASS & STENTS over sold

Understanding Atherosclerosis & its MI Link--jk

Atherosclerosis how it causes over 90% of heart attacks

 

This article heavily relies upon Wikipedia and 40 years of reading sporadically, medical-science articles on the topics raised--jk.

 

There are two types of plaque formations stable and unstable. Stenosis (occlusion) over 75% accounts for about 14% of mycondria infractions, while those under 50% occlusions account for  more likely it is to be stable

 

Arteriosclerosis is a general term describing any hardening and thus loss of elasticity of medium or large arteries.

 

Arteriolosclerosis of the small arteries

 

Atherosclerosis is a hardening of an artery due to atheromatous plaque.  (Atherosclerosis is thus a type of arteriosclerosis.)

Atheromatous plaqye is divided into three compenents:

            1.  The atheroma (from greek athera meaning porridge), which is the nodular accumulation of a soft, flaky, yellowish material at the center of a large plaque.

            2.  Underlying areas ofr cholesterol crystals.

            3.  Calcification at the outer base of older more advanced lesions. 

 

THE PROCESS:  Atherosclerosis develops from low-density lipoprotein cholesterol (LDL), colloquially called "bad cholesterol". Most researchers believe that, when this lipoprotein gets through the wall of an artery, oxygen free radicals  react with it to form oxidized –LDL.  The body’s immune system responds by sending specialized white blood cells (marcophages and T-lymphocytes) to absorb the oxidized-LDL.  These white blood cells are not able to process the oxidized-LDL, and ultimately grow, then rupture and in so doing deposit the oxidized LDL within the artery wall.  This trigtgers more white blood cells thereby continuing the cycle. 

 

Eventually the artery become inflamed.  The cholesterol plaque causes the muscle cells in the artery wall to enlarge and from a hard cover over the affected area.  This hard cover is what causes a narrowing of the artery, which results in a reduced blood flow and increased blood pressure. 

 

Another mechanism (less well understood) results from chronic infection which affect the vascular smooth muscle cells.  Chickens, for example, develop atherosclerosis when infected with Maek’s disease herpesvirus.  Herpesvirus infetion of arterial smooth muscle cells has been shown to casue cholesteryl ester (CE) accumulation. Cholesteryl ester accumulation is associated with atherosclerosis. 

 

Atherosclerosis is a life long process.  For example, autopsies of soldiers killed in the Korean and Vietnam Wars revealed that they showed evidence of the disease.  Another necropsy study revealed that 1 in 6 teenagers demonstrated coronary atherosclerosis, and 85% of the subjects older than 50.[i]  In the U.S. (data for 2004), about 65% of men and 47% of women, the first symptom of atherosclerotic cardiovascular disease is a heart attack.  Most artery flow disrupting events occur at locations with less than 50% lumen narrowing (~20% stenosis is average).  [Reader should note that most illustrations and photographs are of extreme narrowing and without compensatory external diameter enlargement.]    

 

There are three problems from plaque formation:  enlargement, restriction of blood flow, and rupture with clogging.  The atheromatous plaques, though long compensated for by artery enlargement, will eventually lead to plaque ruptures and stenosis (narrowing) of the artery, and therefore, an insufficient blood supply to the organ it feeds.  If the compensating artery enlargement process is excessive, then an aneurysm results.  These complications are chronic, slowly progressing and cumulative.  The third problem comes from the sudden ruptures, which cause the formation of thrombus that will rapidly slow or stop blood flow.  This leads to death of the tissues fed by the artery in approximately 5 minutes.  This catastrophic event is called an infraction.   When it occurs in a coronary artery is causes a myocardial infraction (MI, a heart attack).  Since atherosclerosis is a body-wide process, similar events occur also in the arteries of the brain (the second most common type of dementia is vascular dementia) intestines, kidneys, legs, etc.  

 

DIAGNOSIS:  Diagnosis of asymptomatic atherosclorsis is traditionally done through a stress test which evaluates the arterial blood flow during physical exercise, compared to blood flow while at rest.  The patient walks on a treadmill while his hart functions are check with an electrocardiogram (ECG). Unfortunately the test only reveals occlusions greater than 75% and most MIs result from those less than 50%.  Individuals with 75% or greater stenosis were found to be responsible for only about 14% of heart attacks.[ii]  Severe stenosis (75% or greater) usually are stable and the less severe stenosis are automatically compensated for by vasodilation (widening or relaxing) of the ventricular arterioles during exercise, and do not usually produce enough of an imbalance of relative blood flow to be detectable by a stress test.   

 

Angiogram or intracoronary ultrasound can provide even greater information, but at the risk of complications associated with cardiac catheterization.  Treadmill tests have a sensitivity of 67%, specificity of 70%.  Nuclear test have a sensitivity of 81%, specificity of 85-95%.  However, for reasons stated above, stenosis is not a good predictor of MI, and thus the correlation of test results to MI is low. 

 

Over the last couple of decades other methods have  been developed for detecting atherosclerotic disease.  These include coronary calcium scoring by CT; (2) carotid IMT (intimal medial thickness) measure by ultrasound; and IVUS (intravascular ultrasound which uses a specially designed catheter with a miniaturized ultrasound probe attached to the distal end of the catheter.[iii]  This latter test allows for an image from inside the blood vessel out through the surrounding blood column, visualizing the endothelium (inner wall) of the blood vessel. 

 

ACCELERATING PLAQUE FORMATION:  (1) Exposure to reactive oxygen is the most common way to accelerate atherosclerosis, and the most common source is carbon monoxide a product of tobacco smoke (including second-hand smoke).  (2) Shut down the shut-off mechanism.  The body’s immune system responds by sending specialized white blood cells (marcophages and T-lymphocytes) to absorb the oxidized-LDL. (This is an active area of research, see _____)  There is also a polypetide which stops this process.  Unfortuantely all COX-2 inhibitors but for aspirin shut off this stop signal.  Taking an NSAID--but for aspirin—thus accelates atherioclorsis (see http://healthfully.org/aspirin/id17.html).  (3) Diabetes and obesity (obesityh is found in 55% of those diagnosed with type 2 diabetes)  High level of blood glucose damage small blood vessels and accelerate plaque formation.  In time the MI risk becomes double that of the general population—about the same as one who smokes a pack a day for 20 years.  Because of the present rate of obesity it is estimated that 1 in 3 Americans born after 2000 will develop diabetes in their lifetime.   

 

TREATMENTS:  The problem with medications insertion of a stent or a bypass operation prior to an MI is that statistically they result in only minor risk reduction.  Because of this imaging and stress testing have little to do with risk reduction.  The best of all interventions are the lifestyle changes of exercise, weight loss, and avoiding tobacco smoke. (Exercise and weight loss reduce blood pressure, a major risk factor.)  Ironically, testing and medical interventions are most efficacious not in themselves but by promoting lifestyle changes.  

 

Medical interventions do far less than is commonly believed.  The best of medical interventions is aspirin which reduce risk of MI by 23% by its effect upon thrombus.  The second best is the taking of a diuretic[iv] to reduce blood pressure—if such be an issue.  For example the bypass operation statically adds about one year to life, however, it does often ameliorate the pain of angina.  As stated before statins help, but mainly, if not entirely, through an aspirin like mechanism that reduce the risk of thrombus.  These conclusions are confirmed by the Framingham Risk Table.[v] 

 

CONCLUSION:  Ad post hoc proctor hoc reasoning and financial considerations have made intervention the norm.   Go to a doctor and ask him for treatment, and it is treatment you’ll get, for that is his source of revenue.  Selling drugs is the source of revenue for big PhARMA.  Performance is measured by the productions of profits.  As for your heart, the best thing is free:  a healthy lifestyle. 

 

 



[i]  High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults, Circulation 2001; 103:2705, also at http://circ.ahajournals.org/cgi/content/abstract/103/22/2705

[ii] Two clinical trials published in late 1990s, focusing on the relation between plaque structure, lumen stenosis and MI, in which each individuals coronary anatomy was tracked with both angiography and IVUS found that 75% or greater stenotic areas were responsible for only about 14% of heart attacks (at http://en.wikipedia.org/wiki/Cardiac_stress_test). 

[iii]  There is a 1% risk of major complication (heart attack, stroke, etc.) from cardiac catheterization. 

[iv] Other expensive drugs have come out to treat high-blood pressure, however, they have been shown to be no more effective than diuretics.  See http://skeptically.org/socialism/id19.html

[v]  Lowering TC (total cholesterol) through drug intervention has little effect upon risk because it is the underlying atherosclerosis that causes the cardiac events, and this condition is not reversed by lowering TC. 

Enter supporting content here

Those who have a financial interest in the outcome manipulate the results, Major study finds that all 37 journal articles positive effects over stated; the average was 32%.

 

STATINS CANCER Link

52% short term

 

LA Times, Health section, July 21, 2008  --  excerpts

Vytorin, the combination drug (simvastatin (better known by its commercial name Zocor) and ezetimibe--known as Zetia) prescribed to lower cholesterol, sustained another blow today, when the author of a major clinical trial announced that the medication had failed to drive down hospitalization and death due to heart failure in patients with narrowing of the aortic valve. In the process, researchers in Norway detected a significant blip in cancers in the 1,800 subjects they followed

Today's findings suggested something more ominous: the incidence of cancer -- and of dying of cancer -- was significantly higher in the patients taking Vytorin. Altogether, 67 patients on placebo developed cancer during the trial. Among subjects on Vytorin, 102 developed cancers of various kinds.*  This is the second adverse press—the first being in March 08, when the ENHANCE trial found that Vytorin fared no better than a placebo at reducing plaque buildup on the walls of patients' arteries.* *

Comments by jk

Simvastatin (Zocor) is off patent.  Thus in a scramble for profits a combination drug (on patent) was introduced.  Direct to consumer market cost $155 in 07—mainly TV ads. 

*  The pressing issue is that since the development  of Statins, the very first animal studies in the 60s it has been known that Statins increase the incidents of cancer.  However, nearly all studies done thereafter have not included cancer. 

*  Several studies have failed to find a reduction in the build of plaque, even thought the statins including Zocor, reduce LDL and cholesterol.  Few studies include the principle reason for taking a statin, namely a reduction in the death rate.  Claims for such reduction probably entail a failure to control the contravening variable, aspirin usage.  Given a pile of evidence, including the very mechanism of plaque formation, which involves inflammation process, I must conclude that the use of statins is highly suspect.  Given the harm done including cognitive impairment, weakness, and cancer, if my skepticism is born out, the harm done by statins as a course of treatment will far surpass that of VIOXX which killed over 200,000 people world wide by accelerating atherosclerosis.